N. Ahmed and P. J. Thornalley, Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo, Annals of the New York Academy of Sciences, vol.1043, pp.260-266, 2005.

C. Antognelli, L. Mezzasoma, K. Fettucciari, E. Mearini, and V. N. Talesa, Role of glyoxalase I in the proliferation and apoptosis control of human LNCaP and PC3 prostate cancer cells, The Prostate, vol.73, pp.121-132, 2013.

P. J. Beisswenger, S. K. Howell, A. D. Touchette, S. Lal, and B. S. Szwergold, Metformin reduces systemic methylglyoxal levels in type 2 diabetes, Diabetes, vol.48, pp.198-202, 1999.

C. F. Bento, F. Marques, R. Fernandes, and P. Pereira, Methylglyoxal alters the function and stability of critical components of the protein quality control, PLoS One, vol.5, p.13007, 2010.

A. Bierhaus, T. Fleming, S. Stoyanov, A. Leffler, A. Babes et al., Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy, Nature Medicine, vol.18, pp.926-933, 2012.

S. K. Calderwood, M. A. Khaleque, D. B. Sawyer, and D. R. Ciocca, Heat shock proteins in cancer: chaperones of tumorigenesis, Trends in Biochemical Sciences, vol.31, pp.164-172, 2006.

W. L. Cheng, M. M. Tsai, C. Y. Tsai, Y. H. Huang, C. Y. Chen et al., Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression, PLoS One, vol.7, p.34352, 2012.

B. Chiavarina, M. J. Nokin, F. Durieux, E. Bianchi, A. Turtoi et al., Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes, Oncotarget, vol.5, pp.5472-5482, 2014.

M. Cordenonsi, F. Zanconato, L. Azzolin, M. Forcato, A. Rosato et al., The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells, Cell, vol.147, pp.759-772, 2011.

M. Deran, J. Yang, C. H. Shen, E. C. Peters, J. Fitamant et al., Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein, Cell Reports, vol.9, pp.495-503, 2014.

D. Dobler, N. Ahmed, L. Song, K. E. Eboigbodin, and P. J. Thornalley, Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification, Diabetes, vol.55, pp.1961-1969, 2006.

S. Dupont, L. Morsut, M. Aragona, E. Enzo, S. Giulitti et al., Role of YAP/TAZ in mechanotransduction, Nature, vol.474, pp.179-183, 2011.

N. Emi, T. Friedmann, and J. K. Yee, Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus, Journal of Virology, vol.65, pp.1202-1207, 1991.

E. Enzo, G. Santinon, A. Pocaterra, M. Aragona, S. Bresolin et al., Aerobic glycolysis tunes YAP/TAZ transcriptional activity, The EMBO Journal, vol.34, pp.1349-1370, 2015.

M. A. Fonseca-sá-nchez, R. Cuevas, S. Mendoza-herná-ndez, G. Bautista-piñ-a, V. et al., Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade, International Journal of Oncology, vol.41, pp.670-680, 2012.

M. Fujii, T. Toyoda, H. Nakanishi, Y. Yatabe, A. Sato et al., TGF-b synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth, The Journal of Experimental Medicine, vol.209, pp.479-494, 2012.

E. Giovannucci, D. M. Harlan, M. C. Archer, R. M. Bergenstal, S. M. Gapstur et al., Diabetes and cancer: a consensus report, Diabetes Care, vol.33, pp.1674-1685, 2010.

Y. Han, E. Randell, S. Vasdev, V. Gill, M. Curran et al., Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complicationfree patients with Type 1 diabetes, Clinical Biochemistry, vol.42, pp.562-569, 2009.

Y. Hao, A. Chun, K. Cheung, B. Rashidi, and X. Yang, Tumor suppressor LATS1 is a negative regulator of oncogene YAP, Journal of Biological Chemistry, vol.283, pp.5496-5509, 2008.

K. F. Harvey, X. Zhang, and D. M. Thomas, The Hippo pathway and human cancer, Nature Reviews Cancer, vol.13, pp.246-257, 2013.

M. He, Z. Zhou, A. A. Shah, Y. Hong, Q. Chen et al., New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics, Cell Division, vol.11, p.4, 2016.

S. E. Hiemer, A. D. Szymaniak, and X. Varelas, The transcriptional regulators TAZ and YAP direct transforming growth factor b-induced tumorigenic phenotypes in breast cancer cells, Journal of Biological Chemistry, vol.289, pp.13461-13474, 2014.

A. R. Hipkiss and C. H. , Carnosine protects proteins against methylglyoxal-mediated modifications, Biochemical and Biophysical Research Communications, vol.248, pp.28-32, 1998.

F. Hosoda, Y. Arai, N. Okada, H. Shimizu, M. Miyamoto et al., Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer, Oncogene, vol.34, pp.1196-1206, 2015.

C. J. Huntoon, M. D. Nye, L. Geng, K. L. Peterson, K. S. Flatten et al., Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway, Cancer Research, vol.70, pp.8642-8650, 2010.

T. Iwamoto, G. Bianchini, D. Booser, Y. Qi, C. Coutant et al., Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer, Journal of the National Cancer Institute, vol.103, pp.264-272, 2011.

Y. Kang, L. G. Edwards, P. Thornalley, Q. Y. Lei, H. Zhang et al., Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA G1 growth arrest and induction of apoptosis, Molecular and Cellular Biology, vol.20, pp.2426-2436, 1996.

T. Lund, A. Svindland, M. Pepaj, A. B. Jensen, J. P. Berg et al., Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans, Diabetes and Vascular Disease Research, vol.8, pp.284-294, 2011.

J. S. Mo, Z. Meng, Y. C. Kim, H. W. Park, C. G. Hansen et al., Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway, Nature Cell Biology, vol.17, pp.500-510, 2015.

T. Moroishi, C. G. Hansen, and K. L. Guan, The emerging roles of YAP and TAZ in cancer, Nature Reviews Cancer, vol.15, pp.73-79, 2015.

M. M. Mulvihill, D. I. Benjamin, J. X. , L. Scolan, E. Louie et al., Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity, Chemistry & Biology, vol.21, pp.831-840, 2014.

K. Nakayama, M. Nakayama, M. Iwabuchi, H. Terawaki, T. Sato et al., Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients, American Journal of Nephrology, vol.28, pp.871-878, 2008.

L. Neckers and P. Workman, Hsp90 molecular chaperone inhibitors: are we there yet?, Clinical Cancer Research, vol.18, pp.64-76, 2012.

M. Overholtzer, J. Zhang, G. A. Smolen, B. Muir, W. Li et al., Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon, PNAS, vol.103, pp.12405-12410, 2006.

T. Oya, N. Hattori, Y. Mizuno, S. Miyata, S. Maeda et al., Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts, The Journal of Biological Chemistry, vol.274, pp.18492-18502, 1999.

T. Oya-ito, Y. Naito, T. Takagi, O. Handa, H. Matsui et al., Heat-shock protein 27 (Hsp27) as a target of methylglyoxal in gastrointestinal cancer, Biochimica Et Biophysica Acta (BBA) -Molecular Basis of Disease, vol.1812, pp.769-781, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00694726

D. Pan, The hippo signaling pathway in development and cancer, Developmental Cell, vol.19, pp.491-505, 2010.

K. T. Pate, C. Stringari, S. Sprowl-tanio, K. Wang, T. Teslaa et al., Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer, The EMBO Journal, vol.33, pp.1454-1473, 2014.

J. T. Price, J. M. Quinn, N. A. Sims, J. Vieusseux, K. Waldeck et al., The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line, Cancer Research, vol.65, pp.4929-4938, 2005.

B. J. Quinn, H. Kitagawa, R. M. Memmott, J. J. Gills, and P. A. Dennis, Repositioning metformin for cancer prevention and treatment, Trends in Endocrinology & Metabolism, vol.24, pp.469-480, 2013.

N. Rabbani and P. J. Thornalley, Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples, Nature Protocols, vol.9, pp.1969-1979, 2014.

B. M. Radu, D. I. Dumitrescu, C. C. Mustaciosu, and M. Radu, Dual effect of methylglyoxal on the intracellular Ca2+ signaling and neurite outgrowth in mouse sensory neurons, Cellular and Molecular Neurobiology, vol.32, pp.1047-1057, 2012.

J. P. Richard, Mechanism for the formation of methylglyoxal from triosephosphates, Biochemical Society Transactions, vol.21, pp.549-553, 1993.

M. Rowlands, C. Mcandrew, C. Prodromou, L. Pearl, A. Kalusa et al., Detection of the ATPase activity of the molecular chaperones Hsp90 and Hsp72 using the TranscreenerTM ADP assay kit, Journal of Biomolecular Screening, vol.15, pp.279-286, 2010.

T. Y. Ryu, J. Park, and P. E. Scherer, Hyperglycemia as a risk factor for cancer progression, Diabetes & Metabolism Journal, vol.38, pp.330-336, 2014.

H. Sakamoto, T. Mashima, S. Sato, Y. Hashimoto, T. Yamori et al., Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells, Clinical Cancer Research, vol.7, pp.2513-2518, 2001.

H. Sakamoto, T. Mashima, K. Yamamoto, and T. Tsuruo, Modulation of heat-shock protein 27 (Hsp27) antiapoptotic activity by methylglyoxal modification, Journal of Biological Chemistry, vol.277, pp.45770-45775, 2002.

T. Santarius, G. R. Bignell, C. D. Greenman, S. Widaa, L. Chen et al., GLO1-A novel amplified gene in human cancer, Genes, Chromosomes and Cancer, vol.49, pp.711-725, 2010.

J. L. Scheijen and C. G. Schalkwijk, Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen, Clinical Chemistry and Laboratory Medicine, vol.52, pp.85-91, 2014.

C. A. Schneider, W. S. Rasband, and K. W. Eliceiri, NIH Image to ImageJ: 25 years of image analysis, Nature Methods, vol.9, pp.671-675, 2012.

Y. Shen, J. Yang, J. Li, X. Shi, L. Ouyang et al., Carnosine inhibits the proliferation of human gastric cancer SGC-7901 cells through both of the mitochondrial respiration and Glycolysis pathways, PLoS One, vol.9, 2014.

Y. Takahashi, Y. Miyoshi, C. Takahata, N. Irahara, T. Taguchi et al., Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers, Clinical Cancer Research, vol.11, pp.1380-1385, 2005.

P. J. Thornalley, L. G. Edwards, Y. Kang, C. Wyatt, N. Davies et al., Antitumour activity of S-pbromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis, Biochemical Pharmacology, vol.51, pp.1365-1372, 1996.

P. J. Thornalley, Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy, General Pharmacology, vol.27, pp.565-573, 1996.

P. J. Thornalley, Dicarbonyl intermediates in the maillard reaction, Annals of the New York Academy of Sciences, vol.1043, pp.111-117, 2005.

C. Tikellis, R. J. Pickering, D. Tsorotes, O. Huet, M. E. Cooper et al., Dicarbonyl stress in the absence of hyperglycemia increases endothelial inflammation and atherogenesis similar to that observed in diabetes, Diabetes, vol.63, pp.3915-3925, 2014.

J. Trepel, M. Mollapour, G. Giaccone, and L. Neckers, Targeting the dynamic HSP90 complex in cancer, Nature Reviews Cancer, vol.10, pp.537-549, 2010.

Z. Turk, Glycotoxines, carbonyl stress and relevance to diabetes and its complications, Physiological Research, vol.59, pp.147-156, 2010.

J. W. Van-heijst, H. W. Niessen, K. Hoekman, and C. G. Schalkwijk, Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine, Annals of the New York Academy of Sciences, vol.1043, pp.725-733, 2005.

J. W. Van-heijst, H. W. Niessen, R. J. Musters, V. W. Van-hinsbergh, K. Hoekman et al., Argpyrimidinemodified Heat shock protein 27 in human non-small cell lung cancer: a possible mechanism for evasion of apoptosis, Cancer Letters, vol.241, pp.309-319, 2006.

D. Waltregny, A. Bellahcè-ne, I. Van-riet, L. W. Fisher, M. Young et al., Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer, JNCI Journal of the National Cancer Institute, vol.90, pp.1000-1008, 1998.

T. Wang, E. F. Douglass, K. J. Fitzgerald, and D. A. Spiegel, A "turn-on" fluorescent sensor for methylglyoxal, Journal of the American Chemical Society, vol.135, pp.12429-12433, 2013.

W. Wang, Z. D. Xiao, X. Li, K. E. Aziz, B. Gan et al., AMPK modulates Hippo pathway activity to regulate energy homeostasis, Nature Cell Biology, vol.17, pp.490-499, 2015.

P. S. Ward and C. B. Thompson, Metabolic reprogramming: a cancer hallmark even warburg did not anticipate, Cancer Cell, vol.21, pp.297-308, 2012.

C. X. Xu, H. H. Zhu, and Y. M. Zhu, Diabetes and cancer: Associations, mechanisms, and implications for medical practice, World Journal of Diabetes, vol.5, pp.372-380, 2014.

A. Yano, S. Tsutsumi, S. Soga, M. J. Lee, J. Trepel et al., Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone, PNAS, vol.105, pp.15541-15546, 2008.

L. Zender, W. Xue, J. Zuber, C. P. Semighini, A. Krasnitz et al., An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer, Cell, vol.135, pp.852-864, 2008.

H. Zhang, C. Y. Liu, Z. Y. Zha, B. Zhao, J. Yao et al., TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition, Journal of Biological Chemistry, vol.284, pp.13355-13362, 2009.

S. Zhang, X. Liang, X. Zheng, H. Huang, X. Chen et al., Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma, International Journal of Clinical and Experimental Pathology, vol.7, pp.2079-2090, 2014.

B. Zhao, X. Ye, J. Yu, L. Li, W. Li et al., TEAD mediates YAP-dependent gene induction and growth control, Genes & Development, vol.22, pp.1962-1971, 2008.